Summary.-Sera from patients with nasopharyngeal carcinoma (NPC), a disease associated with Epstein-Barr virus (EBV), were found to be cytotoxic at 15°C in the presence of complement for a panel of human lymphocytes, with a higher frequency than those of matched controls. The cold lymphocytotoxic antibodies (LTA) responsible for this activity have the same properties as those described in sera from individuals with acute viral infections. The frequency and geometric mean titres (GMT) of LTA varied with the origin of the patient (Chinese > North African > Caucasian) and the stage of the disease (Stage IV > Stage I). A positive correlation between LTA and anti-EBV titres was found with regard to antibodies to the viral capsid antigen (VCA) and the EBV-specified nuclear antigen (EBNA). The absence of correlation between LTA and anti-early antigen (EA) titres probably reflects the complex relationships existing between viral infection and LTA production, but is compatible with the hypothesis that LTA acts as an immune regulatory mechanism in viral infections.
CYTOTOXIC activity against a panel of human lymphocytes, complement-dependent and optimal at 15°C, was described by Mottironi and Terasaki in patients with acute viral infections such as infectious mononucleosis, rubella and measles . This low-avidity antibody, known as cold lymphocytotoxic antibody (LTA), was later found in various pathological conditions, including systemic lupus erythematosus (SLE) (Terasaki, Mottironi and Barnett, 1970; Mittal et al., 1970; Ooi et al., 1974; Winchester et al., 1974) , parasitic infections (Mayer, Falkenrodt and Tongio, 1973) and pernicious anaemia (Goldberg, Cunningham and Terasaki, 1972) . In SLE patients, the presence of LTA was found to correlate with that of antibodies to native DNA and single-stranded RNA (DeHoratius et al., 1975 (Ho, 1972) . This tumour is associated with infection by Epstein-Barr virus (EBV) (reviewed by de-The, Ho and Muir, 1976) , the causative agent of infectious mononucleosis (IM) and, at least among the high-risk group of Southern Chinese, is linked with a characteristic HLA haplotype (Simons et al., 1975b) . Because of this association between NPC and EBV, we have examined whether LTA was produced in the patients with NPC, as it is in IM patients.
In the study reported here, sera from NPC cases and control individuals obtained from each of the 3 geographical areas were examined for the presence and titres of LTA and anti-EBV antibodies. It will be shown that: (1) LTA is present with higher frequency and at higher titres in sera from NPC patients than in the control sera; (2) both geographical origin and the stage of the disease influence the production of LTA; and (3) a positive correlation exists between LTA and anti-EBV titres in NPC sera.
MATERIALS AND METHODS
Tests and control sera.-Ninety-eight sera from patients with NPC, diagnosed in Hong Kong (43) , Tunis (42) and Paris (13) were selected so that the various stages of the disease (Ho, 1970) EB V serology.-Antibodies against viral capsid antigen (VCA) and early antigen (EA) were titrated by the indirect immunofluorescence technique as described by Henle (Henle and Henle, 1966; Henle et al., 1970b) . The anticomplement immunofluorescence test of Reedman and Klein (1973) (Table I) In all results reported below, the cytotoxic activity of LTA+ sera was shown to be complement-dependent and, in agreement with the postulated IgM nature of the antibodies (Chalopin et al., 1975) , DTT-sensitive. The absorp- (P value) of the difference between NPC andl control groups. tion of a few highly positive sera with platelets, polymorphonuclear cells and EBV-positive B lymphoblastoid cells (Line 4091) has no effect, in contrast to the loss of cytotoxicity after absorption with T lymphocytes. Finally, the observations that sera with a titre > 4 were cytotoxic for > 80% of the cells in all of the lymphocyte suspensions from the panel indicated that the specificity was not restricted to a small subset of T cells.
The frequency of LTA+ sera, as well as the GMT of these positive sera, was higher in the NPC than in the control groups, for both Caucasians (620/o v 17% and 1-7 vs 141 respectively) and Chinese (84% vs 28% and 3'2 vs 1.2 respectively). The frequency of LTA+ sera was identical (64%) in Tunisian NPC cases and controls, although their GMT was higher in the NPC than in the control group (2.4 vs 1-3; P < 0 01). Finally, when the GMTs of LTA+ NPC sera from different geographical areas were compared, they ranged from I P7 for Caucasians to 2-4 for Tunisians and 3-2 for Chinese: the difference between Caucasians and Chinese is significant (P < 0*01).
2. LTA in NPC at different stages of the disease (Table II) As the criterion for determining the stage of the disease was slightly different in Hong Kong than in the other areas, comparison was first made between different stages (I + II, III and IV) among the homogeneous Chinese group. The frequency of LTA+ sera was similar in the 3 groups. However, when their GMTs were compared, they were found to increase steadily with the stage (2-0; 3 0; 449). These 2 last values were significantly higher (P<0 05 and P<0 01, respectively) than the GMT of positive control sera.
The comparison between stages, irrespective of the geographical origin of the patients, resulted in difficulties, owing to slight differences in the criteria used for staging and to different levels of LTA between groups of NPC patients according to their origin (see above). Despite this increased heterogeneity in the sampling, the difference in LTA between Stages (I + II) and IV was still significant (Table III) .
3. LTA and anti-EBV antibodies in lNPC patients (Table IV) All NPC sera were examined for the presence and titre of antibodies against the VCA of EBV. A positive correlation between titres of LTA and of anti-VCA antibodies was found in the Chinese (Old et al., 1966; Henle et al., 1970a; De Schryver et al., 1969; . That this might correspond to an increase in the antigenic load is supported by the frequent appearance, during NPC evolution, of antibodies directed against EBV early antigens (Henle, 1971) . Further indication that EBV was associated with NPC came from the discovery that its genome is present in the malignant epithelial cells (Wolf, zur Hausen and Becker, 1973; Desgranges et al., 1975) . Besides its association with EBV, NPC has a geographical distribution characterized by a high frequency among Cantonese Chinese, and low frequency among Caucasians, the frequency among North African populations being intermediate. The high risk is attributable, at least partly, to some genetically determined factor which might be of immunological nature (Simons et al., 1975a) . Thus among Southern Chinese the high risk has conclusively been shown to be associated with the specific HLA-A2, B Sin2 haplotype (Simons et al., 1975a) .
LTA is known to be produced during the acute phase of various viral infections, where it might represent some nonspecific by-product of the antibody response, either against virus-modified cell membranes or against structures characteristic of cells from the stimulated clones, thus reflecting some operating regulatory processes. As there is a suggestion that EBV might be " reactivated " in NPC patients, resulting in high titres of specific anti-EBV antibody, it was interesting to examine the production of LTA in those circumstances.
Our results show that the incidence and GMT of LTA+ sera is higher among NPC patients than among controls in the Chinese and the Caucasian groups. In the North African group, the incidence of LTA was as high among matched controls as among NPC patients. This high frequency of LTA in the normal population was confirmed when sera from " healthy " Tunisian students were examined. Fifty-five per cent (17/31) were LTA+, but again their GMT was low (1.4). The reason for this " high background " of LTA was not due to any technical or sampling problem and remains unclear. The possible role of parasitic infestations (Mayer et al., 1973) could not be assessed in this unexpected observation.
When the frequencies and levels of LTA in NPC patients from different geographical areas were compared, the highest values were found in the Chinese group, the lowest in the Caucasian group. This parallels the risk for NPC in these different areas. The difference in GMT, significant at the 1% level between Chinese and Caucasian LTA+ sera, did not result from an unequal distribution of stages between the geographically determined samples, did not reflect different levels of LTA in the corresponding normal populations, but likewise parallels the incidence of NPC in the different geographical areas.
An interesting observation was that the GMT of LTA among NPC patients rose with tumour progression. This could not be ascribed to therapy, since all patients in these series were bled prior to treatment. The tumour burden is not, however, a sufficient condition for inducing LTA production. That the presence of LTA is not an obligatory sideeffect of tumour development, is illustrated by the follow-up of a Caucasian population of 75 breast cancers: 17 (23%) were positive as compared to 8 out of 40 (20%) in the age-sex matched control population. These percentages remained stable during and following cobaltotherapy (up to 3 months) (Revillard et al., unpublished) .
In contrast, a high incidence and high GMT of LTA were found in a series of 15 Ugandan patients with Burkitt's lymphoma (BL) (a second EBV-associated tumour). The unexpected finding that they did not differ significantly from that of 14 controls, prevented any interpretation. Here again the picture might have been obscured by the heavy parasitic infection (Mayer et al., 1973) in tropical areas.
Most associations of LTA with pathological situations have been found with acute viral infections, including the EBVcaused IM , or diseases in which the role of a virus is suspected Mittal et al., 1970; Ooi et al., 1974; Winchester et al., 1974) . The best studied example is SLE, where a correlation between the finding of LTA and anti-nuclear antibodies has been reported (DeHoratius et al., 1975) . A representative sample of the sera entered in this LTA study is now analysed for anti-nuclear factors, another antibody activity described in sera from NPC cases (see below). Our finding of a positive correlation between titres of anti-VCA antibody and LTA and, among Tunisians (the only group studied) between anti-EBNA antibody and LTA, supports the interpretation that LTA and active viral infections have a close relationship. The failure to find a correlation between anti-EA (a marker of EBV-replication) and LTA titres might be only an apparent paradox. This is, indeed, the kind of result expected when two parameters, linked by a feedback mechanism, are compared without taking into account the onset of the regulatory mechanism.
An interesting control group would be normal individuals with a high anti-EBV reactivity. This is, however, unrealistic, since such a high reactivity is characteristic of IM, NPC and BL, all circumstances in which LTA is indeed produced. Finally, it is tempting to speculate on the possible relationship between NPC and LTA. The development of an NPC tumour probably results from multifactorial events in which EBV and genetic factor(s) may play important roles.
In addition to the observations mentioned above, the existence of a link, in a given geographical area, between the incidence of NPC and the proportion of NPC with high LTA titres, indirectly supports the hypothesis that EBV plays a role in NPC. If, indeed, EBV reactivation is one of the single events (or a co-factor) increasing the probability at which NPC occurs and is, at the same time, responsible for LTA production, then a difference in the frequency of this reactivation is expected to result in parallel variations on both the incidence of NPC in the general population and the level of LTA in these patients.
As to the possible role of genetic factors, it rests on the discovery by Simons et al. (1975a) of an association, among Singapore Chinese, between NPC and the specific A 2, B Sin2, HLA haplotype. The association of NPC with a given major histocompatibility complex (MHC) haplotype suggests the existence in this disease, as in many others (Moller, 1975) , of an MHC-specific " disease susceptibility gene " (McDevitt and Bodmer, 1974) . Furthermore, the finding in Chinese patients with NPC of hyporesponsiveness in vivo to purified protein derivative and in vitro to phytohaemagglutinin (Chan et al., 1976) , as well as the high incidence of antinuclear factors (Yoshida, 1971; Yoshida, Yasuda-Yasaki and Utsumi, 1975 ) is consistent with an immunologic component in the pathogenesis of NPC, and raises the possibility that the " disease susceptibility gene " may exert its function by regulating immune responsiveness. The ability to develop LTA, an antibody with specificity mainly restricted to T lymphocytes (Lies, Messner and Williams, 1973) , might represent another facet of this genetically determined " susceptibility ". The comparison, in frequency and GMT, of LTA+ sera between individuals with and without the haplotype associated with high risk for NPC might provide some clue for testing this hypothesis.
